Microscopic colitis and its associations with complications observed in classic inflammatory bowel disease: a systematic review

References

• Nguyen GC, Smalley WE, Vege SS, et al. American gastroenterological association institute guideline on the medical management of microscopic colitis. Gastroenterology. 2016;150:242–246.
   PubMed Web of Science ®Google Scholar
• Vigren L, Olesen M, Benoni C, et al. An epidemiological study of collagenous colitis in southern Sweden from 2001–2010. World J Gastroenterol. 2012;18:2821–2826.
   PubMed Web of Science ®Google Scholar
• Munch A, Aust D, Bohr J, et al. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis. 2012;6:932–945.
   PubMed Web of Science ®Google Scholar
• Langner C, Aust D, Ensari A, et al.; The Working Group of Digestive Diseases of the European Society of Pathology (ESP) and the European Microscopic Colitis Group (EMCG). Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology. 2015;66:613–626.
   PubMed Web of Science ®Google Scholar
• Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease – microscopic colitis? Aliment Pharmacol Ther. 2012;36:79–90.
   PubMed Web of Science ®Google Scholar
• Fernández-Bañares F, Esteve M, Farré C, et al. Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis. Eur J Gastroenterol Hepatol. 2005;17:1333–1338.
   PubMed Web of Science ®Google Scholar
• Westerlind H, Mellander MR, Bresso F, et al. Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis. Gut. 2017;66:421–428.
   PubMed Web of Science ®Google Scholar
• Long MD, Hutfless S, Kappelman MD, et al. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis. 2014;20:398–415.
   PubMed Web of Science ®Google Scholar
• Wolters FL, Russel MG, Sijbrandij J, et al. Crohn’s disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut. 2006;55:510–518.
   PubMed Web of Science ®Google Scholar
• Hoie O, Schouten LJ, Wolters FL, et al.; On behalf of the European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD). Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut. 2007;56:497–503.
   PubMed Web of Science ®Google Scholar
• Karlinger K, Györke T, Makö E, et al. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol. 2000;35:154–167.
   PubMed Web of Science ®Google Scholar
• Pedersen N, Duricova D, Elkjaer M, et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480–1487.
   PubMed Web of Science ®Google Scholar
• Kappelman MD, Farkas DK, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12:265–273.e1.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al.; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. [cited 2019 Dec 20]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Wickbom A, Nyhlin N, Montgomery SM, et al. Family history, comorbidity, smoking and other risk factors in microscopic colitis: a case-control study. Eur J Gastroenterol Hepatol. 2017;29:587–594.
   PubMed Web of Science ®Google Scholar
• Kao KT, Pedraza BA, McClune AC, et al. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol. 2009;15:3122–3127.
   PubMed Web of Science ®Google Scholar
• Yen EF, Pokhrel B, Bianchi LK, et al. Decreased colorectal cancer and adenoma risk in patients with microscopic colitis. Dig Dis Sci. 2012;57:161–169.
   PubMed Web of Science ®Google Scholar
• Roth B, Manjer J, Ohlsson B. Microscopic colitis is associated with several concomitant diseases. Drug Target Insights. 2013;7:19–25.
   PubMedGoogle Scholar
• Tontini GE, Pastorelli L, Spina L, et al. Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea: a prospective, multicenter study. Inflamm Bowel Dis. 2014;20:882–891.
   PubMed Web of Science ®Google Scholar
• Sonnenberg A, Genta RM. Low prevalence of colon polyps in chronic inflammatory conditions of the colon. Am J Gastroenterol. 2015;110:1056–1061.
   PubMed Web of Science ®Google Scholar
• Levy A, Borren NZ, Maxner B, et al. Cancer risk in microscopic colitis: a retrospective cohort study. BMC Gastroenterol. 2019;19:1.
   PubMed Web of Science ®Google Scholar
• Gu HX, Zhi FC, Huang Y, Li AM, et al. Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China. Int J Colorectal Dis. 2012;27:1167–1173.
   PubMed Web of Science ®Google Scholar
• Lorinczy K, Lakatos G, Mullner K, et al. Low bone mass in microscopic colitis. BMC Gastroenterol. 2011;11:58.
   PubMed Web of Science ®Google Scholar
• Wildt S, Munck LK, Becker S, et al. Risk of osteoporosis in microscopic colitis. Postgrad Med. 2018;130:348–354.
   PubMed Web of Science ®Google Scholar
• Guagnozzi D, Lucendo AJ, Angueira-Lapeña T, et al. Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain. Dig Liver Dis. 2012;44:384–388.
   PubMedGoogle Scholar
• Fragoulis GE, Liava C, Daoussis D, et al. Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment. World J Gastroenterol. 2019;25:2162–2176.
   PubMed Web of Science ®Google Scholar
• Masclee GM, Coloma PM, Kuipers EJ, et al. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal antiinflammatory drugs. Am J Gastroenterol. 2015;110:749–759.
   PubMed Web of Science ®Google Scholar
• Kobayashi J. Effect of diet and gut environment on the gastrointestinal formation of N-nitroso compounds: a review. Nitric Oxide. 2018;73:66–73.
   PubMed Web of Science ®Google Scholar
• Carmack SW, Lash RH, Gulizia JM, et al. Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist. Adv Anat Pathol. 2009;16:290–306.
   PubMed Web of Science ®Google Scholar
• Ohlsson B. New insights and challenges in microscopic colitis. Therap Adv Gastroenterol. 2015;8:37–47.
   PubMed Web of Science ®Google Scholar
• Vigren L, Sjoberg K, Benoni C, et al. Is smoking a risk factor for collagenous colitis? Scand J Gastroenterol. 2011;46:1334–1339.
   PubMed Web of Science ®Google Scholar
• Munch A, Tysk C, Bohr J, et al. Smoking status influences clinical outcome in collagenous colitis. J Crohns Colitis. 2016;10:449–454.
   PubMed Web of Science ®Google Scholar
• de Vries AB, Janse M, Blokzijl H, et al. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol. 2015;21:1956–1971.
   PubMed Web of Science ®Google Scholar
• Vigren L, Tysk C, Strom M, et al. Celiac disease and other autoimmune diseases in patients with collagenous colitis. Scand J Gastroenterol. 2013;48:944–950.
   PubMed Web of Science ®Google Scholar
• Larsson JK, Dabos KJ, Hoglund P, et al. Cancer risk in collagenous colitis. J Clin Med. 2019;8:1942.
   PubMed Web of Science ®Google Scholar